Shaolin Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Shaolin Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-114,273	Closed	-$9K	–	1042
2023 Q1	$9K	Sell	114,273 -16,034	-12%	-$4.18K	﹤0.01%	645
2022 Q4	$20K	Hold	130,307	–	–	﹤0.01%	588
2022 Q3	$17K	Hold	130,307	–	–	﹤0.01%	750
2022 Q2	$20K	Buy	130,307 +25,607	+24%	+$8.29K	﹤0.01%	839
2022 Q1	$39K	Buy	104,700 +210	+0.2%	+$108	﹤0.01%	816
2021 Q4	$100K	Buy	+104,490	New	+$109K	﹤0.01%	652

Shaolin Capital Management's ORIAW Position: Q2 2023 in Review

Shaolin Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 114,273 shares — an estimated $9K sold.

Shaolin Capital Management first reported a position in ORIAW in Q4 2021 and held it in 6 quarters. The position peaked at $100K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Shaolin Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Shaolin Capital Management sold 114,273 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $9K.
Shaolin Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2021 and held it in 6 quarters.
Shaolin Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $100K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Shaolin Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.